Dr. Hussein Tawbi on Efficacy and Safety Results From the CheckMate 204 Melanoma Trial

Leggi l'articolo originale


Cancer Network spoke with Hussein Tawbi, MD, PhD, of MD Anderson Cancer Center, about the efficacy and safety of the combination of nivolumab plus ipilimumab in patients with symptomatic melanoma brain metastases.

Lascia un commento